Gastroenterology
Volume 141, Issue 5 , Pages 1792-1801 , November 2011

Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome

  • Mirjana Rajilić–Stojanović

      Affiliations

    • Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands
    • Department of Biochemical Engineering and Biotechnology, Faculty of Technology and Metallurgy, University of Belgrade, Belgrade, Serbia
  • ,
  • Elena Biagi

      Affiliations

    • Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands
  • ,
  • Hans G.H.J. Heilig

      Affiliations

    • Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands
  • ,
  • Kajsa Kajander

      Affiliations

    • Valio Ltd, R&D, Helsinki, Finland
  • ,
  • Riina A. Kekkonen

      Affiliations

    • Valio Ltd, R&D, Helsinki, Finland
  • ,
  • Sebastian Tims

      Affiliations

    • Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands
  • ,
  • Willem M. de Vos

      Affiliations

    • Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands
    • Departments of Veterinary Biosciences and Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
    • Corresponding Author InformationReprint requests Address requests for reprints to: Willem M. de Vos, PhD, Laboratory of Microbiology, Wageningen University, Dreijenplein 10, 6703 HB Wageningen, The Netherlands. fax: +31317483829

Received 8 May 2011 ,Accepted 27 July 2011.

References 

  1. Longstreth GF , Thompson WG , Chey WD , et al.   Functional bowel disorders . Gastroenterology . 2006;130:1480–1491
  2. Bengtson MB , Ronning T , Vatn MH , et al.   Irritable bowel syndrome in twins: genes and environment . Gut . 2006;55:1754–1759
  3. Spiller RC . Inflammation as a basis for functional GI disorders . Best Pract Res Clin Gastroenterol . 2004;18:641–661
  4. Dunlop SP , Hebden J , Campbell E , et al.   Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes . Am J Gastroenterol . 2006;101:1288–1294
  5. Spiller RC , Garsed K . Post-infectious irritable bowel syndrome . Gastroenterology . 2009;136:1979–1988
  6. Zoetendal EG , Rajilić-Stojanović M , de Vos WM . High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota . Gut . 2008;57:1605–1615
  7. Collins SM , Bercik P . The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease . Gastroenterology . 2009;136:2003–2014
  8. Spiller RC . Review article: Probiotics and prebiotics in irritable bowel syndrome . Aliment Pharmacol Ther . 2008;28:385–396
  9. Pimentel M , Lembo A , Chey MD , et al.   Rifaximin therapy for patients with irritable bowel syndrome without constipation . N Engl J Med . 2011;156:3205–3215
  10. Zoetendal EG , Akkermans ADL , Akkermans-van Vliet W , et al.   The host genotype affects the bacterial community in the human gastrointestinal tract . Microbial Ecol Health Dis . 2001;13:129–134
  11. Kassinen A , Krogius-Kurikka L , Mäkivuokko H , et al.   The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects . Gastroenterology . 2007;133:24–33
  12. Salonen A , de Vos WM , Palva A . Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives . Microbiology . 2010;156:3205–3215
  13. Rajilić-Stojanović M , Smidt H , de Vos WM . Diversity of the human gastrointestinal tract microbiota revisited . Environ Microbiol . 2007;9:2125–2136
  14. Rajilić-Stojanović M , Heilig HGHJ , Molenaar D , et al.   Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults . Environ Microbiol . 2009;11:1736–1751
  15. Claesson MJ , O'Sullivan O , Wang Q , et al.   Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine . PLoS One . 2009;4:e6669
  16. Arumugam M , Raes J , Pelletier E , et al.   Enterotypes of the human gut microbiome . Nature . 2011;473:174–180
  17. Kajander K , Myllyluoma E , Rajilić-Stojanović M , et al.   Multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilises intestinal microbiota . Aliment Pharmacol Ther . 2008;27:48–57
  18. Kekkonen RA , Lummela N , Karjalainen H , et al.   Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults . World J Gastroenterol . 2008;14:2029–2036
  19. Thompson WG , Longstreth GF , Drossman DA , et al.   Functional bowel disorders and functional abdominal pain . Gut . 1999;45(Suppl 2):43–47
  20. Lepš J , Šmilauer P . Multivariate analysis of ecological data using CANOCO . Cambridge, UK: Cambridge University Press; 2003;
  21. Swidsinski A , Weber J , Loening-Baucke V , et al.   Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease . J Clin Microbiol . 2005;43:3380–3389
  22. Malinen E , Krogius-Kurikka L , Lyra A , et al.   Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome . World J Gastroenterol . 2010;16:4532–4540
  23. Ley RE , Turnbaugh PJ , Klein S , et al.   Microbial ecology: human gut microbes associated with obesity . Nature . 2006;444:1022–1023
  24. Diamant M , Blaak EE , de Vos WM . Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? . Obes Rev . 2011;4:272–281
  25. Buhner S , Li Q , Vignali S , et al.   Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome . Gastroenterology . 2009;137:1425–1434
  26. Giovanni B , Vincenzo S , Roberto DG , et al.   Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome . Gastroenterology . 2004;126:693–702
  27. Klooker TK , Braak B , Koopman KE , et al.   The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome . Gut . 2010;59:1213–1221
  28. Macfarlane GT , Allison C , Gibson SA , et al.   Contribution of the microflora to proteolysis in the human large intestine . J Appl Bacteriol . 1988;64:37–46
  29. Smith EA , Macfarlane GT . Studies on amine production in the human colon: enumeration of amine forming bacteria and physiological effects of carbohydrate and pH . Anaerobe . 1996;2:285–297
  30. Malinen E , Rinttilä T , Kajander K , et al.   Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR . Am J Gastroenterol . 2005;100:373–382
  31. Kerckhoffs APM , Samsom M , van der Rest ME , et al.   Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients . World J Gastroenterol . 2009;15:2887–2892
  32. Parkes GC , Sanderson JD , Whelan K . Treating irritable bowel syndrome with probiotics: the evidence . Proc Nutr Soc . 2010;69:187–194
  33. Ivanov D , Emonet C , Foata F , et al.   A serpin from the gut bacterium Bifidobacterium longum inhibits eukaryotic elastase-like serine proteases . J Biol Chem . 2006;281:17246–17252
  34. Ventura M , O'Flaherty S , Claesson MJ , et al.   Genome-scale analyses of health-promoting bacteria: probiogenomics . Nat Rev Microbiol . 2009;7:61–71
  35. Lyra A , Krogius-Kurikka L , Nikkila J , et al.   Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes . BMC Gastroenterol . 2010;10:110
  36. Liu C , Finegold SM , Song Y , et al.   Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov., Blautia producta comb. nov., Blautia schinkii comb. nov. and description of Blautia wexlerae sp. nov., isolated from human faeces . Int J Syst Evol Microbiol . 2008;58:1896–1902
  37. Tana C , Umesaki Y , Imaoka A , et al.   Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome . Neurogastroenterol Motil . 2010;22:512–519
  38. Sokol H , Pigneur B , Watterlot L , et al.   Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients . Proc Natl Acad Sci U S A . 2008;105:16731–16736
  39. Sokol H , Seksik P , Furet JP , et al.   Low counts of Faecalibacterium prausnitzii in colitis microbiota . Inflamm Bowel Dis . 2009;15:1183–1189
  40. Bayliss CE , Bradley HK , Jones VA , et al.   Some aspects of colonic microbial activity in irritable bowel syndrome associated with food intolerance . Ann Ist Super Sanita . 1986;22:959–963
  41. Booijink CC , El-Aidy S , Rajilić-Stojanović M , et al.   High temporal and inter-individual variation detected in the human ileal microbiota . Environ Microbiol . 2010;12:3213–3227
  42. Biagi E , Nylund L , Candela M , et al.   Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians . PLoS One . 2010;5:e10667
  43. Scully P , McKernan DP , Keohane J , et al.   Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity . Am J Gastroenterol . 2010;105:2235–2243
  44. Rana S , Sharma S , Sinha S , et al.   Incidence of predominant methanogenic flora in irritable bowel syndrome patients and apparently healthy controls from North India . Dig Dis Sci . 2009;54:132–135
  45. King TS , Elia M , Hunter JO . Abnormal colonic fermentation in irritable bowel syndrome . Lancet . 1998;352:1187–1189
  46. Vernia P , Camillo MD , Marinaro V , et al.   Effect of predominant methanogenic flora on the outcome of lactose breath test in irritable bowel syndrome patients . Eur J Clin Nutr . 2003;57:1116–1119

 Conflicts of interest The authors disclose no conflicts.

 Funding This work was partially funded by the unrestricted Spinoza Award of the Netherlands Organization of Scientific Research awarded to WMdV.

PII: S0016-5085(11)01076-6

doi: 10.1053/j.gastro.2011.07.043

Gastroenterology
Volume 141, Issue 5 , Pages 1792-1801 , November 2011